TauRx Alzheimer's drug fails in large study; some benefit seen
July 27, 2016 at 08:00 AM EDT
CHICAGO, July 27 (Reuters) - TauRx Pharmaceuticals' experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's disease, a large, late-stage study showed.
